As of 2025-12-27, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (13.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -2067.1%.
The range of the Relative Valuation is (9.79) - (18.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 14.8x | 10.0x |
| Forward P/E multiples | 7.7x - 15.7x | 11.7x |
| Fair Price | (9.79) - (18.75) | (13.76) |
| Upside | -1500.0% - -2780.7% | -2067.1% |
| Date | P/E |